Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds CRSPCRISPR THERAPEUTICS AG

13 funds on our shelf carry CRISPR THERAPEUTICS AG — heaviest hand: GNOM at 2.63% of its book.

FundWeightFund assetsShares held
GNOMGlobal X Genomics & Biotechnology ETFINDEX2.63%$85M53,513
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.28%$317M82,800
XBIState Street SPDR S&P Biotech ETFINDEX1.02%$10.3B2,006,430
IBBiShares Biotechnology ETFINDEX0.32%$10.6B683,169
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.32%$112M7,402
VTWVVanguard Russell 2000 Value ETFINDEX0.29%$813M72,079
IWNiShares Russell 2000 Value ETFINDEX0.28%$13.9B759,792
RSSLGlobal X Russell 2000 ETFINDEX0.16%$1.5B42,797
ISCViShares Morningstar Small-Cap Value ETFINDEX0.16%$661M20,690
VTWOVanguard Russell 2000 ETFINDEX0.16%$9.9B522,730
IWMiShares Russell 2000 ETFINDEX0.15%$74.2B2,256,374
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFINDEX0.10%$349M6,887
XTiShares Exponential Technologies ETFINDEX0.02%$4.1B18,613

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.